Changes to the publication dates of Revenio’s financial reports in 2026

Revenio Group Corporation changes the publishing dates of its 2026 January-June Half-year report and January-September Interim report.

Revenio will publish the following financial reports in 2026:

• Half-year report 1-6/2026 on Tuesday, September 8, 2026 (previously August 6, 2026)
• Interim report 1-9/2026 on Thursday, November 11, 2026 (previously October 29, 2026)

For further information, please contact
CEO Jouni Toijala
+358 50 484 0085
jouni.toijala@revenio.fi

Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Main media
www.reveniogroup.fi/en

Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix. 

In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.